NCT06231654

Brief Summary

Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jul 2025Jul 2026

First Submitted

Initial submission to the registry

December 21, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
1.4 years until next milestone

Study Start

First participant enrolled

July 2, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2026

Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

December 21, 2023

Last Update Submit

January 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • measure of heart rate (HR) with remote photo-plethysmography (rPPG) at 30 seconds of recording

    Assess the reliability of HR measurement using the rPPG at 30 seconds of recording versus that measured using ECG electrodes, the method taken as the gold standard, in a pediatric population

    at inclusion

Secondary Outcomes (8)

  • HR measurement using rPPG at 60 seconds of recording

    at inclusion

  • RR measurement using rPPG (60-second recording)

    at inclusion

  • RR measurement using rPPG (30-second recording)

    at inclusion

  • RR measurement using rPPG according to the age ranges ranking

    at inclusion

  • HR measurement using rPPG according to the age ranges ranking

    at inclusion

  • +3 more secondary outcomes

Study Arms (1)

patents

EXPERIMENTAL

the child will be placed in a dedicated, quiet, well-lit office with their parents. The following data are then collected: sex, age, phototype according to Fitzpatrick's classification. The child sits in a chair facing a camera connected to a laptop running Caducy® Medical Device software. At the same time, and following the usual procedure, three ECG electrodes will be positioned on the patient.

Device: Remote photoplethysmography for physiological parameters

Interventions

Patients participating in the study will be recruited from our emergency department. The child will be placed in a dedicated, quiet, well-lit office with their parents. The following data are then collected: sex, age, phototype according to Fitzpatrick's classification. The child sits in a chair facing a camera connected to a laptop running Caducy® Medical Device software. At the same time, and following the usual procedure, three ECG electrodes will be positioned on the patient. The whole device is connected to our standard device. Once the child is immobile and ready, the Caducy® application is launched. At the same time, our standard device is activated. After 30 seconds, we will collect the HR and FR values revealed by the Caducy® application via the non-contact plethysmography method. On the other hand, it will collect the HR and FR values revealed by our standard device (Mindray® scope).

patents

Eligibility Criteria

Age3 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children under 18 and over 3 years of age
  • Any reason for consultation or hospitalization
  • Written and signed informed consent from one parent or the person with parental authority,
  • Membership of a social security scheme

You may not qualify if:

  • Patient with a neurocognitive disorder
  • Patient in immediate vital distress,
  • Known cardiac arrhythmia,
  • Scleroderma
  • Patients suffering from pathological tremors or muscle spasms that prevent them from remaining static for the duration of the measurement.
  • Parents who do not understand and/or speak French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL

Nice, 06200, France

RECRUITING

Related Publications (1)

  • Haas-Ferrua S, Giaccardi H, Ancey B, Freyssinet E, Baranton E, Joulie A, Bendimerad I, Olla M, De Oliveira F, Moussaoui A, Boyer L, Fontas E, Tran A. Measurement of heart rate and respiratory rate using remote photoplethysmography in paediatrics: a prospective comparative trial protocol - 'rMonitoped1'. BMJ Open. 2026 Mar 19;16(3):e104840. doi: 10.1136/bmjopen-2025-104840.

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 30, 2024

Study Start

July 2, 2025

Primary Completion (Estimated)

July 2, 2026

Study Completion (Estimated)

July 2, 2026

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations